Chugai Pharmaceutical Co. (CHGCY)
(Delayed Data from OTC)
$23.12 USD
+0.11 (0.48%)
Updated Sep 19, 2025 03:59 PM ET
3-Hold of 5 3
C Value B Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
For Chugai Pharmaceutical Co., Ltd. Unsponsored ADR, the company has a dividend yield of 2.50% compared to the Medical - Drugs industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CHGCY 23.12 +0.11(0.48%)
Will CHGCY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CHGCY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHGCY
Are Medical Stocks Lagging AngioDynamics (ANGO) This Year?
Chugai Pharmaceutical Co. (CHGCY) Upgraded to Buy: Here's Why
CHGCY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?
Other News for CHGCY
Eli Lilly upgraded at HSBC after latest trial win for obesity pill
Chugai Pharmaceutical (CHGCY) Sees Stock Surge After Eli Lilly Trial Success
Chugai spikes after Eli Lilly trial win for obesity pill
Market Today: MongoDB (MDB) Surges on Strong Q2 Results
Macquarie Healthcare Fund Q2 2025 Commentary